JODEAN CLARK: Open Payments
NPI 1851955819 · KEY WEST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,472 in 51 payments from 29 companies in 2025. Trend: 2023 $1,795 · 2024 $1,773 · 2025 $1,472
Food & beverage: $1,472
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $136 |
| Eisai Inc. | 2 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| AstraZeneca Pharmaceuticals LP | 4 | $106 |
| Janssen Biotech, Inc. | 4 | $106 |
| Merck Sharp & Dohme LLC | 4 | $104 |
| Caris MPI, Inc. | 1 | $89 |
| Daiichi Sankyo Inc. | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $66 |
| Invivyd Inc | 2 | $60 |
Products named: SARCLISA, Lenvima, Enhertu, KEYTRUDA, MI CANCER SEEK, TALVEY, PEMGARDA, SCEMBLIX.
Industry payments across FL — which companies pay providers there.
